The first mpox vaccine approved by the WHO is MVA-BN, made by Bavarian Nordic A/S. It was approved for emergency use and can be used "off-label" in infants, children and adolescents as well as in ...

In a statement late Tuesday, the U.N. health agency said it had approved the mpox vaccine made by Japanese company KM Biologics for use in children over one year of age as a single dose.

GENEVA - The World Health Organisation (WHO) on Nov 19 approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency’s seal of approval.

The only other vaccine being used against the mpox outbreak is Bavarian ... In Europe, it is known as Imvanex, where it is also approved in adults and adolescents, the latter indication coming ...

The World Health Organization on Tuesday approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency's seal of approval. The WHO said it ...